Access Biotechnology

Access Biotechnology is an investment arm of Access Industries that focuses on private and public biopharma companies.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Access Biotechnology Information

Geographic Data

Access Biotechnology headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Access Biotechnology is the life science investment arm of Access Industries. They invest in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health. They invest in both private and public biopharma companies across therapeutic areas, modalities, and development stages – from discovery-stage technology platforms to late-stage clinical programs. The company is based in New York.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
6/2022 Upstream Bio Series A 200M
7/2022 Areteia Therapeutics Series A 0
11/2021 Matchpoint Therapeutics Seed 30M
5/2021 Eliem Therapeutics Series B 0
3/2021 Eliem Therapeutics Series A 80M
7/2021 Nimbus Therapeutics Private Equity Round 105M
7/2020 Verona Pharma Private Placement 200M
10/2019 Disc Medicine Series A 50M
9/2022 Nimbus Therapeutics Venture Round 0
9/2021 Disc Medicine Post-IPO Equity 0
11/2021 Recludix Pharma Series A 60M
9/2021 Disc Medicine Series B 90M
2/2023 Hemab Series B 0
8/2022 Disc Medicine Post-IPO Equity 0
12/2021 Curie Therapeutics Series A 75M
2/2021 Day One Biopharmaceuticals Series B 130M
9/2022 ACELYRIN Series C 0
4/2020 Pandion Therapeutics Series B 80M
3/2021 DTx Pharma Series B 100M
6/2023 Upstream Bio Series B 0
2/2023 Hemab Series B 0
9/2022 ACELYRIN Series C 0
9/2022 Nimbus Therapeutics Venture Round 0
8/2022 Disc Medicine Post-IPO Equity 0
7/2022 Areteia Therapeutics Series A 0
6/2022 Upstream Bio Series A 0
12/2021 Curie Therapeutics Series A 0
11/2021 Recludix Pharma Series A 0
11/2021 Matchpoint Therapeutics Seed Round 0
9/2021 Disc Medicine Post-IPO Equity 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research